<?xml version="1.0" encoding="ASCII"?>
<biogps><data><item key="owner">ArrayExpress Uploader</item><item key="pop_total">0</item><item key="species">human</item><item key="factors"><item><item key="GSM428146 1"/></item><item><item key="GSM428147 1"/></item><item><item key="GSM428148 1"/></item><item><item key="GSM428149 1"/></item><item><item key="GSM428150 1"/></item><item><item key="GSM428151 1"/></item><item><item key="GSM428152 1"/></item><item><item key="GSM428153 1"/></item><item><item key="GSM428154 1"/></item><item><item key="GSM428155 1"/></item><item><item key="GSM428156 1"/></item><item><item key="GSM428157 1"/></item><item><item key="GSM428158 1"/></item><item><item key="GSM428159 1"/></item></item><item key="id">3352</item><item key="ownerprofile_id">arrayexpress_sid</item><item key="platform">4</item><item key="summary_wrapped">We generated the transcriptional regulatory footprint of phthalimide neovascular factor 1 (PNF1)&#8212;a novel synthetic small molecule that...</item><item key="geo_gse_id">E-GEOD-17119</item><item key="owner_profile">/profile/8773/arrayexpressuploader</item><item key="factor_count">0</item><item key="sample_count">14</item><item key="tags"><item>serum</item></item><item key="lastmodified">Dec.12, 2014</item><item key="is_default">False</item><item key="geo_gds_id"/><item key="slug">transcriptional-profiling-of-a-novel-pro-angiogeni</item><item key="geo_id_plat">E-GEOD-17119_A-AFFY-44</item><item key="name">Transcriptional profiling of a novel pro-angiogenic small molecule phthalimide neovascular factor 1 (PNF1)</item><item key="created">Sep.12, 2014</item><item key="summary">We generated the transcriptional regulatory footprint of phthalimide neovascular factor 1 (PNF1)&#8212;a novel synthetic small molecule that exhibits significant in vitro endothelial potency and significant in vivo microvascular network expansion&#8212;by performing comparative microarray analysis on PNF1-stimulated (versus control) human microvascular endothelial cells (HMVEC) spanning 1-48 h post-supplementation.  We subsequently applied network analysis tools (including substantial libraries of information regarding known associations among network components) to elucidate key signaling components and pathways involved in the PNF1 mechanism-of-action.  We identified that PNF1 first induces function of the tumor necrosis factor-alpha (TNF-&#945;) signaling pathway, which in turn affects transforming growth factor-beta (TGF-&#946;) signaling. HMVEC (Cambrex, Walkersville, MD, USA) were cultured in endothelial growth medium 2-microvascular (bulletkit, BioWhittaker, Walkersville, MD, USA) supplemented as directed with 5% fetal bovine serum. The cells (passage 9) were plated at 2.5 x 104 cells/cm2 at 37 degrees Celsius in a humidified chamber with 5% carbon dioxide. They were grown to confluence. After confluence, medium was refreshed, and 30 &#181;M PNF1 or 0.6% dimethyl sulfoxide (DMSO) vehicle control was added to the sample. Total RNA from the PNF1 (n=1 at each timepoint) and control (n=1 at each timepoint) samples was isolated 1, 2, 4, 8, 16, 24 and 48 h post-supplementation using an RNeasy kit (Qiagen, Inc., Valencia, CA, USA) according to the manufacturer's protocol.</item><item key="source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-17119</item><item key="sample_source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-17119/samples/</item></data></biogps>
